Fever management in intensive care patients with infections

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Young, Paul J ^a   Saxena, Manoj ^b  

^a WELLINGTON HOSPITAL   (New Zealand)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; GLUCOCORTICOID; HEAT SHOCK PROTEIN; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLACEBO; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL INFECTION; BACTERIAL PERITONITIS; CORE TEMPERATURE; CRITICALLY ILL PATIENT; CYTOKINE RELEASE; ENZYME ACTIVITY; FEVER; HEAT LOSS; HERPES SIMPLEX; HUMAN; HYPERTHERMIA; INFECTION; INFLUENZA VIRUS; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE INFECTION; META ANALYSIS (TOPIC); NEISSERIA MENINGITIDIS; NONHUMAN; ORGANUM VASCULOSUM OF THE LAMINA TERMINALIS; PASTEURELLA MULTOCIDA INFECTION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; STREPTOCOCCUS PNEUMONIA; THERMOGENESIS; THERMORECEPTOR; THERMOREGULATION; VIRUS INFECTION; ANIMAL; COMMUNICABLE DISEASES; DISEASE MANAGEMENT; INTENSIVE CARE UNIT; PROCEDURES; TRENDS;

ANIMALS; COMMUNICABLE DISEASES; DISEASE MANAGEMENT; FEVER; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS;

EID: 84899076714     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13773     Document Type: Review

References (50)

1. Osler W. The study of the fevers of the south. JAMA 1986, XXVI:1001-1004.
2. Niven DJ, Stelfox HT, Laupland KB. Antipyretic therapy in febrile critically ill adults: A systematic review and meta-analysis. J Crit Care 2013, 28:303-310. 10.1016/j.jcrc.2012.09.009, 23159136.
3. Jefferies S, Weatherall M, Young P, Eyers S, Perrin KG, Beasley CR. The effect of antipyretic medications on mortality in critically ill patients with infection: a systematic review and meta-analysis. Crit Care Resus 2011, 13(1):25-131.
4. Horvath SM, Spurr GB, Hutt BK, Hamilton LH. Metabolic cost of shivering. J Appl Physiol 1956, 8:595-602.
5. Manthous CA, Hall JB, Olson D, Singh M, Chatila W, Sohlman A, Kushner R, Schmidt GA, Wood LD. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med 1995, 151:10-14. 10.1164/ajrccm.151.1.7812538, 7812538.
6. Chu CM, Tian SF, Ren GF, Zhang YM, Zhang LX, Liu GQ. Occurrence of temperature-sensitive influenza A viruses in nature. J Virol 1982, 41:353-359. 256765, 7077746.
7. Small PM, Tauber MG, Hackbarth CJ, Sande MA. Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits. Infect Immun 1986, 52:484-487. 261024, 3699893.
8. Enders JF, Wu CJ, Shaffer MF. Studies on natural immunity to pneumococcus type III: IV. Observations on a non-type specific humoral factor involved in resistance to pneumococcus type III. J Exp Med 1936, 64:425-438. 10.1084/jem.64.3.425, 2133433, 19870545.
9. Moench M. A study of the heat sensitivity of the meningococcus in vitro within the range of therapeutic temperatures. J Lab Clin Med 1926, 57:665-676.
10. Khanna MR, Bhavsar SP, Kapadnis BP. Effect of temperature on growth and chemotactic behaviour of Campylobacter jejuni. Lett Appl Microbiol 2006, 43:84-90. 10.1111/j.1472-765X.2006.01904.x, 16834726.
11. Bernheim HA, Kluger MJ. Fever: effect of drug-induced antipyresis on survival. Science 1976, 193:237-239. 10.1126/science.935867, 935867.
12. Reynolds WW. Fever and antipyresis in the bluegill sunfish, Lepomis macrochirus. Comparative biochemistry and physiology. Comp Biochem Physiol C 1977, 57:165-167. 10.1016/0306-4492(77)90065-X, 20274.
13. Kluger M. The evolution of fever. Fever: Its Biology, Evolution, anc Function 1979, 106-127. Princeton University Press, New Jersey, Kluger M, 1.
14. Strouse S. Experimental Studies on Pneumococcus Infections. J Exp Med 1909, 11:743-761. 10.1084/jem.11.5.743, 2124739, 19867282.
15. Armstrong C. Some recent research in the field of neurotropic viruses with especial reference to lymphocytic choriomeningitis and herpes simplex. Mil Surg 1942, 91:129-145.
16. Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R. The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med 2010, 103:403-411. 10.1258/jrsm.2010.090441, 2951171, 20929891.
17. Kluger MJ, Vaughn LK. Fever and survival in rabbits infected with Pasteurella multocida. J Physiol 1978, 282:243-251. 1282736, 309939.
18. Akins C, Thiessen D, Cocke R. Lipopolysaccharide increases ambient temperature preference in C57BL/6J adult mice. Physiol Behav 1991, 50:461-463. 10.1016/0031-9384(91)90095-6, 1745695.
19. Jiang Q, Cross AS, Singh IS, Chen TT, Viscardi RM, Hasday JD. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. infect immun 2000, 68:1265-1270. 10.1128/IAI.68.3.1265-1270.2000, 97277, 10678936.
20. Jefferies S, Weatherall M, Young P, Eyers S, Beasley R. Systematic review and meta-analysis of the effects of antipyretic medications on mortality in Streptococcus pneumoniae infections. Postgrad Med J 2012, 88:21-27. 10.1136/postgradmedj-2011-130217, 22121249.
21. Stanley ED, Jackson GG, Panusarn C, Rubenis M, Dirda V. Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 1975, 231:1248-1251. 10.1001/jama.1975.03240240018017, 163931.
22. Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J infect Dis 1990, 162(1):277-1282.
23. Sperber SJ, Sorrentino JV, Riker DK, Hayden FG. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bull N Y Acad Med 1989, 65:145-160. 1807791, 2557947.
24. Kramer MS, Naimark LE, Roberts-Brauer R, McDougall A, Leduc DG. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet 1991, 337:591-594. 10.1016/0140-6736(91)91648-E, 1671951.
25. Wagner-Jauregg J. The treatment of dementia paralytica by malaria innoculation. Nobel Lectures: Physiology or Medicine 1922-1941 1927, 159-169. Elsevier New York.
26. Owens C. The value of fever therapy for gonorrhea. JAMA 1936, 107:1942-1946.
27. Ahkee S, Srinath L, Ramirez J. Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis. South Med J 1997, 90:296-298. 10.1097/00007611-199703000-00006, 9076300.
28. Weinstein MP, Iannini PB, Stratton CW, Eickhoff TC. Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 1978, 64:592-598. 10.1016/0002-9343(78)90578-8, 645725.
29. Bryant RE, Hood AF, Hood CE, Koenig MG. Factors affecting mortality of gram-negative rod bacteremia. Arch intern Med 1971, 127:120-128. 10.1001/archinte.1971.00310130124022, 4923385.
30. Laupland KB, Shahpori R, Kirkpatrick AW, Ross T, Gregson DB, Stelfox HT. Occurrence and outcome of fever in critically ill adults. Crit Care Med 2008, 36:1531-1535. 10.1097/CCM.0b013e318170efd3, 18434882.
31. Young P, Saxena M, Eastwood GM, Bellomo R, Beasley R. Fever and fever management among intensive care patients with known or suspected infection: a multicentre prospective cohort study. Crit Care Med 2011, 13:97-102.
32. Selladurai S, Eastwood GM, Bailey M, Bellomo R. Paracetamol therapy for septic critically ill patients: a retrospective observational study. Crit Care Resus 2011, 13:181-186.
33. Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, letsegu K, Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, Koh SO, Takeda S, Saito S, Hong SJ, Yamamoto T, Yokoyama T, Yamaguchi T, Nishiyama T, Igrashi T, Kakihana Y, Koh Y. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Fever and Antipyretic in Critically il patients Evaluation (FACE) Study Group. Crit Care 2012, 16:R33. 3396278, 22373120.
34. Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Jamali S, Souweine B, Darmon M, Timsit JF. Determinants of temperature abnormalities and influence on outcome of critical illness. Crit Care Med 2012, 40:145-151. 10.1097/CCM.0b013e31822f061d, 21926588.
35. Young PJ, Saxena M, Beasley R, Bellomo R, Bailey M, Pilcher D, Finfer S, Harrison D, Myburgh J, Rowan K. Early peak temperature and mortality in critically ill patients with or without infection. intensive Care Med 2012, 38:437-444.
36. Niven DJ, Stelfox HT, Shahpori R, Laupland KB. Fever in adult ICUs: An interrupted time series analysis. Crit Care Med 2013, 41:1863-1869. 10.1097/CCM.0b013e31828a43b2, 23782970.
37. Kiekkas P, Velissaris D, Karanikolas M, Aretha D, Samios A, Skartsani C, Baltopoulos GI, Filos KS. Peak body temperature predicts mortality in critically ill patients without cerebral damage. Heart Lung 2010, 39:208-216. 10.1016/j.hrtlng.2009.06.019, 20457341.
38. Moran JL, Peter JV, Solomon PJ, Grearly B, Smith T, Ashforth W, Wake M, Peake SL, Peisach AR. Tympanic temperature measurements: are they reliable in the critically ill? A clinical study of measures of agreement. Crit Care Med 2007, 35:155-164. 10.1097/01.CCM.0000250318.31453.CB, 17095941.
39. Circiumaru B, Baldock G, Cohen J. A prospective study of fever in the intensive care unit. Intensive Care Med 1999, 25:668-673. 10.1007/s001340050928, 10470569.
40. Peres Bota D, Lopes Ferreira F, Melot C, Vincent JL. Body temperature alterations in the critically ill. intensive Care Med 2004, 30:811-816. 10.1007/s00134-004-2166-z, 15127194.
41. Barie PS, Hydo LJ, Eachempati SR. Causes and consequences of fever complicating critical surgical illness. Surg infect (Larchmt) 2004, 5:145-159. 10.1089/sur.2004.5.145, 15353111.
42. Bernard GR, Reines HD, Halushka PV, Higgins SB, Metz CA, Swindell BB, Wright PE, Watts FL, Vrbanac JJ. Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome Effects of cyclooxygenase inhibition. Am Rev Respir Dis 1991, 144:1095-1101. 10.1164/ajrccm/144.5.1095, 1952438.
43. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB, The Ibuprofen in Sepsis Study Group The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997, 336:912-918. 10.1056/NEJM199703273361303, 9070471, The Ibuprofen in Sepsis Study Group.
44. Memis D, Karamanlioglu B, Turan A, Koyuncu O, Pamukcu Z. Effects of lornoxicam on the physiology of severe sepsis. Crit Care 2004, 8:R474-R482. 10.1186/cc2969, 1065065, 15566594.
45. Morris PE, Promes JT, Guntupalli KK, Wright PE, Arons MM. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care 2010, 14:R125. 10.1186/cc9089, 2911773, 20591173.
46. Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB, The Ibuprofen Study Group Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. Crit Care Med 1991, 19:1339-1347. 10.1097/00003246-199111000-00006, 1935150, The Ibuprofen Study Group.
47. Schulman C, Namias N, Doherty J, Manning RJ, Li P, Elhaddad A, Lasko D, Amortequi J, Dy CJ, Dlugasch L, Baracco G, Cohn SM. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg infect (Larchmt) 2005, 6:369-375. 10.1089/sur.2005.6.369, 16433601.
48. Niven DJ, Stelfox HT, Leger C, Kubes P, Laupland KB. Assessment of the safety and feasibility of administering antipyretic therapy in critically ill adults: A pilot randomized clinical trial. J Crit Care 2013, 28:296-302. 10.1016/j.jcrc.2012.08.015, 23102531.
49. Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med 2012, 185:1088-1095. 10.1164/rccm.201110-1820OC, 22366046.
50. Young PJ, Saxena MK, Bellomo R, Freebairn RC, Hammond NE, van Haren FM, Henderson SJ, McArthur CJ, McGuiness SP, Mackle D, Myburgh JA, Weatherall M, Webb SA, Beasley RW, ANZICS Clinical Trials Group The HEAT trial: a protocol for a multicentre randomised placebo-controlled trial of IV paracetamol in ICU patients with fever and infection. Crit Care Resus 2012, 14:290-296. ANZICS Clinical Trials Group.